Surviving in biotech by own means : -if there is a will there is a way

Sweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly....

Full description

Bibliographic Details
Main Authors: Olsson Rousset, Ann, Wismenius, Anna
Format: Others
Language:English
Published: Stockholms universitet, Företagsekonomiska institutionen 2006
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6299
id ndltd-UPSALLA1-oai-DiVA.org-su-6299
record_format oai_dc
collection NDLTD
language English
format Others
sources NDLTD
topic Business studies
Företagsekonomi
spellingShingle Business studies
Företagsekonomi
Olsson Rousset, Ann
Wismenius, Anna
Surviving in biotech by own means : -if there is a will there is a way
description Sweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who toSweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who to Sweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who to talk to talk to and in which order and have good contact with opinion leaders.
author Olsson Rousset, Ann
Wismenius, Anna
author_facet Olsson Rousset, Ann
Wismenius, Anna
author_sort Olsson Rousset, Ann
title Surviving in biotech by own means : -if there is a will there is a way
title_short Surviving in biotech by own means : -if there is a will there is a way
title_full Surviving in biotech by own means : -if there is a will there is a way
title_fullStr Surviving in biotech by own means : -if there is a will there is a way
title_full_unstemmed Surviving in biotech by own means : -if there is a will there is a way
title_sort surviving in biotech by own means : -if there is a will there is a way
publisher Stockholms universitet, Företagsekonomiska institutionen
publishDate 2006
url http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6299
work_keys_str_mv AT olssonroussetann survivinginbiotechbyownmeansifthereisawillthereisaway
AT wismeniusanna survivinginbiotechbyownmeansifthereisawillthereisaway
_version_ 1716512856544903168
spelling ndltd-UPSALLA1-oai-DiVA.org-su-62992013-01-08T13:13:41ZSurviving in biotech by own means : -if there is a will there is a wayengOlsson Rousset, AnnWismenius, AnnaStockholms universitet, Företagsekonomiska institutionenStockholms universitet, Företagsekonomiska institutionen2006Business studiesFöretagsekonomiSweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who toSweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who to Sweden is the fourth largest biotechnology country in Europe and Sweden has the highest number of biotech companies per capita in the world. The sector is not yet a well established one and there haven’t been much energy put on business research, why we wanted to explore the sector more thoroughly. The purpose of our investigation was to examine different ways to survive on your own in the biotech sector. The ways should work to copy for other actors in the biotech sector. Many variables have been taken into account, such as the idea generating process, the business concept, the innovation strategy and the environmental context. The problem to be investigated was: how do you survive by own means in the biotech sector? Our main conclusion is that if there is a will there is a way to survive in the biotech sector. We have distinguished three paths, a MBO offspring, refinement of a brilliant idea and to develop a new medical application, that have been used by several of the biotech companies which we think could be suitable to others. However we are aware of the limited data in this thesis and we couldn’t state that there are other possible paths as well. Our other conclusion is that there are some variables that you need to concentrate on in the company’s different phases. In the beginning you need to focus on your idea and build up your knowledge platform. It is preferred to have another product in licensed to sell during this first period. When you have reached the main scientific goals you need to direct focus towards marketing and sales in order to create revenue for the company. You must also have a plan of who to talk to talk to and in which order and have good contact with opinion leaders. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6299application/pdfinfo:eu-repo/semantics/openAccess